Business Wire

THALES

18.2.2021 16:56:12 CET | Business Wire | Press release

Share
French Armed Forces to Rely on Thales Expertise to Expand Their Secure Satellite Communication Capabilities

Thales has been chosen by the French defence procurement agency (DGA) to lead a second part of the ground segment of the Syracuse IV satellite communications system for the French armed forces. The Group was selected to supply the satellites in 2015 and to lead the first increment of the ground segment in 2019. This second capacity increment will enhance the interoperable communications capabilities of the French Army, Navy and Air Force in terms of data rate, availability, threat resistance and end-to-end connectivity.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210218005759/en/

Military satellite communications are more critical than ever and more vulnerable to attack; they are at the heart of the battle for strategic independence across all areas of military invention. Maintaining connectivity is key to the armed forces' ability to share information of all types between command centres and units deployed on any type of mission, including coalition operations.

This crucial programme milestone will enhance the performance of the ground segment across all theatres of operation for the three branches of the French military. The Thales solution will decisive in meeting the capacity requirements of land, naval and air force programmes such as Scorpion, FREMM, FDI, Barracuda, aircraft carrier, or Rafale. It aims to increase tenfold the secure communication capabilities of fighting vehicles on the move, surface vessels, submarines, and now also aircrafts. The Thales technology guarantees roaming communications in both X- and Ka-band and fully exploits the multi-spot potential of High Throughput Satellite (HTS) technology.

All the ground terminals in the system will be able to make optimum use of the Syracuse IV constellation. Their full interconnection via new docking terminals will allow considerable increase in data rate by ensuring joint cooperation in theatres of operations and with command centres. They will also be compatible with third-party satellite resources, depending on the area of deployment, without compromising communications security.

To achieve this objective, Thales will leverage its high-level systems integration expertise, and in particular its highly secure Modem 21 transmission system, to guarantee the availability and confidentiality of all communications and provide protection from the full spectrum of threats with no impact on operational performance, which is key to retaining information superiority in high-intensity combat. Thales’s NATO-standard Modem 21 solution has been proven in combat for over ten years.

The role of Thales Alenia Space in this contract will include mission management for the Syracuse constellation and management of the anchoring capabilities of the operator, the French Defence Ministry's joint infrastructure networks and information systems agency (DIRISI). Thales Alenia Space is also lead contractor for the contract notified by the DGA at the end of 2015 for the supply of the space segment consisting of the Syracuse 4A and 4B satellites and their control and mission ground segment.

Building on its expertise as a technology orchestrator and integrator for satellite communication systems in France and internationally, Thales has deployed over 1,000 secure, protected satcom stations worldwide, working with local industrial partners.

“As prime contractor for the Syracuse III and Syracuse IV ground segments since 2004, Thales is proud to strengthen its partnership with the French Ministry for the Armed Forces to help maintain the informational superiority of the country’s armed forces in highly contested environments. The sovereign satcom solutions to be supplied under this contract are resilient to all types of threats, combat-proven, and fully interoperable with the systems deployed by NATO coalition forces.” Marc Darmon, Executive Vice President, Secure Communications and Information Systems, Thales.

Note to editors

Syracuse is a series of protected telecommunication satellites designed to ensure that the French armed forces can communicate at all times between mainland France and units deployed around the world. The Syracuse programme provides a fully independent solution to France’s wide-ranging requirements for long-range, secure communication capabilities that are protected against electronic warfare threats. Three generations of Syracuse satellites were deployed between 1984 and 2015. The Syracuse IV programme will replace the Syracuse 3A and Syracuse 3B satellites currently in orbit, while delivering an expanded and upgraded network of ground stations. A constellation of two satellites has been ordered under the first phase of the Syracuse IV programme. They will be built by Thales Alenia Space and Airbus Defence and Space. The first satellite will enter service in 2022.

About Thales

Thales (Euronext Paris: HO) is a global high technology leader investing in digital and “deep tech” innovations –connectivity, big data, artificial intelligence, cybersecurity and quantum technology – to build a future we can all trust, which is vital to the development of our societies. The company provides solutions, services and products that help its customers – businesses, organisations and states – in the defence, aeronautics, space, transportation and digital identity and security markets to fulfil their critical missions, by placing humans at the heart of the decision-making process.

With 83,000 employees in 68 countries, Thales generated sales of €19 billion in 2019 (on a basis including Gemalto over 12 months).

PLEASE VISIT

Thales Group

Download photos

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release

Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release

Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye